Authors: GUDEX CM HAWTHORNE MR BUTLER AG DUFFEY POF

Citation: Cm. Gudex et al., MEASURING PATIENT BENEFIT FROM BOTULINUM TOXIN IN THE TREATMENT OF DYSTONIA - FEASIBILITY OF COST-UTILITY ANALYSIS, PharmacoEconomics, 12(6), 1997, pp. 675-684